Stock Expert AI
Keurig Dr Pepper Inc.
KDP - NASDAQ - $32.04 ▲ +%1.20
-
Earnings Mon 26 Oct

Keurig opens the
books on Monday evening.

8 analysts' median target is $38[FMP target], stock is $32, +18.6% upside potential. After Q2 +6.1% EPS beat[FMP earnings], the stock moved -1.2%.

summary below
Quick Take - in 40 seconds
C+
BUY Council 2/6 - Moonshot 60

C+ = MoonshotScore 60[multi-pillar formula] + Council 2/6[6-lens rule]. Form 4: 0 transactions[FMP Form 4].

Keurig Dr Pepper Inc. (KDP) Q1 consensus: revenue $7.3B[FMP est], EPS $0.64[FMP est]. 7 consecutive quarters of beat[FMP earnings].

$0.64 EPS Estimate Last year $0.39 - +19% YoY YoY
7 Beat Streak Expectations beaten consecutively for the last 7 quarters

Q2 EPS +6.1% beat[FMP] but the stock -1.2% D+1[FMP D+1]. Anthony DiSilvestro promised $181.0M CapEx + a sequential decline in Q1 during the Q2 earnings call[Anthony DiSilvestro capex transcript].

Watchlist

4 metrics stand out this quarter.

30% Investor Focus

Us Refreshment Beverages Growth

us_refreshment_beverages_growth

The U.S. Refreshment Beverages segment achieved double-digit net sales and operating income growth, driven by Dr Pepper Zero Sugar's nearly 30% retail sales growth and the energy drinks portfolio crossing the 9% market share threshold.

"Segment net sales and operating income each grew at a double-digit rate in the second quarter, reflecting strength across both our core portfolio and newer growth platforms. ... Dr Pepper's Zero Sugar platform sustained its momentum, growing retail sales nearly 30% and gaining more share than any other trademark in the Zero Sugar space..."

- Timothy Cofer, CEO - Q2 FY26 Earnings Call - August 6, 2026
25% Investor Focus

Us Coffee Segment Challenges

us_coffee_segment_challenges

The U.S. Coffee segment experienced a low single-digit decline in net sales and a 25% drop in operating income due to higher input costs and category volume declines, but expects improving trends in the back half of the year.

"Turning first to U.S. Coffee. Second quarter performance was relatively consistent with our first quarter as net sales declined in the low single digits and operating income declined 25%. Year-over-year profit pressure was primarily driven by the impact of significantly higher input costs. ... Importantly, we continue to have line of sight to improving segment trends over the balance of the year."

- Timothy Cofer, CEO - Q2 FY26 Earnings Call - August 6, 2026
2% Expectation / Guide

Fy26 Eps Outlook Adjustments

fy26_eps_outlook_adjustments

KDP reaffirmed its 2026 EPS outlook, expecting a neutral impact from an incremental 2% noncash expense headwind due to JDE Peet's purchase price allocation and an anticipated one-time cash benefit from tariff refunds.

"While our EPS outlook is unchanged, there are 2 new elements to highlight. First, during the second quarter, we completed the initial JDE Peet's purchase price allocation. This resulted in higher fixed asset depreciation expense for the acquired entity than we previously anticipated, and our guidance now incorporates an incremental 2% noncash expense headwind to 2026 EPS versus our prior view. Second, our outlook also now includes an anticipated onetime cash benefit from tariff refunds. On a net basis, we expect these 2 factors to largely offset, resulting in a neutral impact to our full year EPS outlook."

- Anthony DiSilvestro, CFO - Q2 FY26 Earnings Call - August 6, 2026
$2.8 billion Investor Focus

Jde Peets Profitability Timing

jde_peets_profitability_timing

The JDE Peet's segment exceeded expectations with $2.8 billion in net sales and $414 million in operating income, benefiting from favorable pricing, productivity savings, and timing factors, though Q2 is expected to be the high watermark for quarterly earnings contribution in 2026.

"Our JDE Peet's segment generated $2.8 billion in net sales and $414 million in operating income in the second quarter, exceeding our expectations. Segment profitability was primarily driven by favorable pricing net of cost inflation, along with robust productivity savings. The business also benefited from timing factors, including related to the recognition of derivative gains as well as some marketing phasing. ... That said, we now believe our second quarter operating profit likely represents the high watermark for JDE Peet's quarterly earnings contribution in 2026..."

- Anthony DiSilvestro, CFO - Q2 FY26 Earnings Call - August 6, 2026

Stock Expert AI - Methodology

Do our scoring pillars, 7 perspectives, and Munger lens point in the same direction?

Council Score 2 / 6 Bullish

6 investor frameworks. 2 bullish (Ray Dalio, Ken Griffin), 0 bearish (none), 4 neutral (Jim Simons, Klarman, Buffett, Munger).

How is it calculated? ->
Ray Dalio macro - target upside +18.6%
Ken Griffin flow - 50d MA above
Jim Simons quant - RSI 59
Klarman value - target upside +18.6%
Buffett quality - ROE score 2/5
Munger valuation - target upside +18.6%
Munger's Mindset character & balance sheet lens
Fairly Valued

Quality business, trading at fair value.

How is it calculated? ->
Financial HealthWeak
Margin of SafetyModerate
Interest CoverageAdequate
ROIC vs WACCTight
Technical Levels - Pre-earnings positioning

What levels is the stock being tested at?

RSI(14)
59.4 RSI 59.4 positive momentum, 50d above
MACD
+2.90 price above 50d - support positive
50d MA
$31 stock 2.9% above - short-term support
200d MA
$29 stock 11.0% above - long-term support
Volume (10d)
-24% decrease - low participation
Resistance
$38
Analyst median target - upgrade trigger if broken
Current
$32
Pre-earnings position
Support
$25
Invalidation - close below this is a technical breakdown
Pattern
Range
$25-$38 band - earnings breakout/breakdown trigger

Past Performance

Keurig's last 8 quarters: 7 consecutive beats.

BEAT
Q3 FY25
$0.54 vs $0.54 est - -1.3%
BEAT
Q4 FY25
$0.60 vs $0.59 est - -2.8%
BEAT
Q1 FY26
$0.39 vs $0.37 est - +2.4%
BEAT
Q2 FY26
$0.57 vs $0.54 est - -1.2%

Q2 (August 6, 2026): EPS $0.57 vs $0.54 est[FMP], +6.1% beat. D+1 movement: -1.2%[FMP D+1]. Decline despite beat - market reacted to guidance, not numbers.

Three scenarios: what could happen?

EPS < $0.62 (no guidance)

Q2: EPS $0.57 vs $0.54 beat[FMP], stock -1.2% D+1[FMP]. Anthony DiSilvestro Q2 transcript: "We continue to expect legacy KDP to grow 4% to 6% in constant currency, but now see the high end of the range as most likely."[Anthony DiSilvestro].

"We continue to expect legacy KDP to grow 4% to 6% in constant currency, but now see the high end of the range as most likely."

- Anthony DiSilvestro, CFO - Q2 FY26 Earnings Call - August 6, 2026
Backlog concentration

No RPO/backlog concentration disclosed in Q2 earnings call.

CapEx shock

Q2 CapEx $181.0M[FMP cashflow]. Q2 op margin 9.2%[FMP op margin] - this level in Q1 is sensitive to CapEx revision risk.

Framework - Position discipline

After the data arrives: 3 scenarios, 3 windows

Not advice - a structural framework for earnings night. Decision discipline is yours.

Scenario A - Beat
Q1 EPS > $0.64 + CapEx discipline
Threshold: EPS > $0.64[FMP est].
Target: Break above median target $38[FMP target]; high target $42[FMP] upper bound.
Scenario B - In-Line
EPS approx $0.64 + CapEx < $181.0M
Threshold: EPS approx $0.64[FMP est], Q1 CapEx < $181.0M[FMP].
Target: Consolidation in the band between current $32[FMP] and median $38[FMP].
Scenario C - Miss
EPS < $0.62 or CapEx >= $181.0M
Threshold: EPS < $0.62[FMP estx0.97].
Target: Current $32 below SMA200 $29[FMP], if rejection continues, $25[derived] support activates.
Sizing
Earnings volatility -> max portfolio 1-2%. Waiting for earnings is not a gamble, it's a position entrustment.
Timing
IV crush within 24 hours post-earnings. Waiting for premium decay makes options preferable to spot.
Staging
Don't go all-in at once, divide into 3: initial reaction, 24 hours later, after Friday's close.

Market Outlook

What do 8 analysts say?

Wall Street Consensus
$38
12-month median target price (+18.6% upside potential)
13
BUY
7
HOLD
0
SELL
Risk Management
$25
Invalidation level - critical support threshold
$31 - 50-day MA (above, +2.9%)
$29 - 200-day MA (above, +11.0%)
IV Crush risk (sudden drop in inflated option premiums before earnings): Option premiums are inflated before earnings.
Verdict - KDP Q1 FY27
C+

You read it in 5 minutes. When the numbers come out on Monday evening - you know what you're looking at.

Data arrives at night. The framework is ready now.

Data arrives on Monday evening. The framework is ready on this page: Q1 EPS threshold $0.64[FMP], CapEx threshold "below $181.0M"[Anthony DiSilvestro]. Two anchors, three scenarios.

Comparison Stock Expert AI Pro $24/month ($240/year), 77% cheaper than the total of three earnings-tracking tools ($1,059/year -> $240/year).

3 subscriptions. 1 platform.

Seeking Alpha $299/yr - analyst opinions + earnings coverage TipRanks $360/yr - Smart Score (1-10) + analyst consensus + insider trades Trendspider $400/yr - AI pattern detection + automated TA + multi-timeframe alerts

Prices as of April 2026. Sources: seekingalpha.com/subscriptions - tipranks.com/pricing - trendspider.com/pricing

Stock Expert AI Pro: $24/month ($240/year). Council 7-lens analysis + MoonshotScore multi-pillar + Insider tracker + Technical levels - all in one platform, for every stock.

Educational tool, not investment advice. Past performance does not guarantee future results.

Calendar

Catalyst Calendar - 90-day forward look

Oct 26, 2026EARNINGSQ1 FY27 results (after market close) + earnings call
Oct 27, 2026PRICEFirst trading day after earnings - 200dMA test + IV crush
Dec 10, 2026FILING10-Q deadline - segment breakdown + RPO detail (SEC rule: quarter-end + 45 days)
~Jan 26, 2027EARNINGSQ2 FY27 (next quarter, date not yet scheduled in FMP)

DATA GAP: Events not in the FMP /stable/calendar feed - Investor day, analyst day, product launches, regulatory dates. These require company IR page scraping or manual calendar entry.

Frequently Asked Questions

What does the KDP earnings preview cover?

This Keurig Dr Pepper Inc. (KDP) earnings preview covers the analyst consensus, key catalysts, and what to watch on the earnings call.

What should investors watch for in KDP earnings?

Keurig Dr Pepper Inc. (KDP): Consensus EPS, revenue guidance, segment growth rates, and the tone of management commentary — the full breakdown with sources is on this page.

Where do the numbers on this page come from?

Keurig Dr Pepper Inc. (KDP): Figures are sourced from Financial Modeling Prep (FMP) fundamentals and consensus data plus official earnings-call transcripts; derived metrics are labeled with their source next to each figure.

Is this a buy or sell recommendation?

Keurig Dr Pepper Inc. (KDP): No. This page is educational research, not investment advice. It summarizes analyst consensus and company data; consult a licensed financial advisor before making any investment decision.

More earnings, decoded